The global cold disposable biopsy forceps market is expected to enjoy a valuation of USD 634.6 Million by 2023, and further expand at a CAGR of 8.2% to reach a valuation of ~USD 1.40 Billion by the year 2033. According to a recent study by Future Market Insights, oval cups by product segment are leading the market with a share of about 46.0% in the year 2023, within the global market.
Market Context:
| Data Points | Market Insights |
|---|---|
| Market Value 2023 | USD 634.6 Million |
| Market Value 2033 | USD 1.40 Billion |
| CAGR 2023 to 2033 | 8.2% |
| Top 5 Countries % Share | 66.0% |
| Key Players | Olympus Corporation, Boston Scientific Corporation, STERIS, CONMED Corporation, Cook Medical, Micro-Tech Endoscopy, Anrei Medical, and others |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for cold disposable biopsy forceps was approximately 29.3% of the overall ~USD 2.0 Billion global biopsy devices market in 2022.
The sale of cold disposable biopsy forceps expanded at a CAGR of 6.6% from 2016 to 2022.
This rise in market share is strongly correlated with variables like the rising cost of healthcare and the rising demand for minimally invasive diagnostic and surgical endoscopic procedures. The use of endoscopic treatments is expanding due to the increased incidence of gastrointestinal problems and bronchitis, which has further fuelled demand for cold disposable biopsy forceps.
Direct tissue sample inspection is still the most important and reliable diagnostic procedure in the field of gastrointestinal endoscopy, despite the rapid growth of diagnostic techniques brought about by the development of novel instruments and related programs. Therefore, a good tissue diagnosis depends on the characteristics of an endoscopic biopsy sample.
The usage of a range of biopsy forceps with various materials and designs is common, even if the fundamental idea behind them has not altered much. A rising focus on improving endoscopic research and development capabilities, backed by regulatory approvals and product releases from major manufacturers, has led to innovative industry improvements.
Additionally, the manufacturers have also made investments in the medical device market because of increased healthcare costs and favorable reimbursement rates. As a result, the disposable biopsy forceps industry will grow at a lucrative pace in the years to come.
The market is thus anticipated to develop significantly over the following ten years at a CAGR of almost 8.4% from 2023 to 2033.
The global market for cold disposable biopsy forceps will experience a significant degree of opportunistic emphasis due to the increasing popularity of the oval cup with a needle, oval cup, alligator jaw with a needle, and alligator jaw. As endoscopic processing technology continues to progress, endoscopic uses are becoming more and more common.
Therefore, manufacturers of cold disposable biopsy forceps may expect to profit from the rise in endoscopic diagnosis and treatment procedures.
As there is a surge in demand and adoption of minimally invasive procedures, ongoing investment is also being made in the development of improved endoscopic instruments. However, the market's leading players are boosting their spending because to the strict government rules relating to patient safety and hygiene.
The introduction of new products with novel technologies has also presented an opportunity for the sector to flourish. Major players making acquisitions is another important marketing tactic in the industry.
For instance, Boston Scientific Corporation completed the acquisition of NxThera in April 2018. The business created the Rezm system, a minimally invasive therapy (MIT) for men with symptomatic benign prostatic hyperplasia (BPH). NxThera joined the urology and pelvic health division of Boston Scientific after the acquisition was finalized.
Principal Consultant
Despite the fact that cold disposable biopsy forceps have advanced, the availability of alternatives for endoscopic procedures may limit market expansion. In comparison to cold biopsy techniques, hot biopsy forceps are thought to cause less procedure-related bleeding without compromising sample quality. This is a significant barrier to the expansion of the cold market.
Additionally, it is anticipated that the high cost of biopsies may restrain market expansion. For instance, according to a survey conducted by Dijion University Hospital, a biopsy session using reusable colonic forceps cost €8.7 (including €1.92 for sterilization costs), while the cost of a biopsy session using reusable gastric forceps was around €7.5 (including €1.92 for sterilization costs) (with the same sterilization cost). Therefore, using reusable biopsy forceps is far preferable to using disposable biopsy forceps from a strictly cost standpoint.
Another important factor that will affect the market's growth is the prevalence of product recalls related to product quality. A bronchoscopy procedure including the use of radial jaw 4 pulmonary single-use biopsy forceps was reported to Boston Scientific Corporation.
The complainant claims that during the process, four to five successful passes via the scope were conducted without any problems. The pull-wire was discovered to be disconnected and the jaws were unable to open after the fifth or sixth time. The pull wires reportedly stayed connected to the gadget and did not detach from the patient. A complaint was made to the FDA because the device had malfunctioned.
These factors thus contribute to the declining growth of the cold disposable biopsy forceps industry.
With a total global market share of about 49.5% in 2023, the USA is anticipated to dominate the market, and it is anticipated that significant growth will continue during the forecast period. The growing elderly population is the factor fuelling the expansion of this market.
The USA Census Bureau predicts that by 2050, there will be 83.7 million people in the age group of 65 years and above, nearly twice as many as there were in 2012.
The baby boomers are primarily responsible for this rise in the number of elderly people. The remaining baby boomers will be older than 85 by 2050. It is important to acknowledge the unique physical and mental health issues that older people experience.
This increase in the elderly population is expected to increase the use and sales of cold disposable biopsy forceps.
Germany is anticipated to hold 4.9% of the global market share in 2023 and is also supposed to gain a steep rise over the forecast duration.
Patients in Germany have frequently reported experiencing an increase in the burden of common gastrointestinal diseases including diarrhea and colorectal cancer.
Furthermore, colorectal cancer is the third most common cancer globally. For instance, according to World Health Organization (WHO), in 2020, around 57,528 individuals were suffering from colorectal cancer in Germany.
This increasing incidence of colorectal cancer is the primary factor influencing regional dominance.
In 2023, Japan is expected to own a market share of 6.6% and is projected to expand at a rapid pace over the forecast duration.
In the 1990s, laparoscopic cholecystectomy was conducted in Japan as the country's first endoscopic procedure. The Japan Society has significantly aided the growth of endoscopic surgery in Japan for Endoscopic Surgery (JSES).
Additionally, during the past ten years, endoscopic operations have dramatically expanded in Japan, which has greatly influenced the current growth in the use of disposable cold biopsy forceps.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The growing preference for oval cup disposable biopsy forceps over other products in the global market for cold disposable biopsy forceps is favored by the fact that the oval cup forceps give deeper epithelial penetration.
According to product segmentation, the disposable oval cup biopsy forceps are anticipated to hold the largest market share of 46.0% in 2023 and continue to expand during the projected period. Endoscopic test samplings during gastrointestinal endoscopy are once more receiving attention as a result of significant advancements in disposable biopsy forceps.
Cold disposable biopsy forceps with a 2.8mm diameter has become more common on the market. A 25.7% of market share is estimated for the 2.8mm diameter in 2023, and growth is foreseen over the course of the forecast period.
Its key benefits of it such as specially designed blades, proprietary sheath design, optimized design, and unique swing jaw are supposed to boost the segment’s growth.
Additionally, sharpened cups with a 2.8 mm diameter offer improved cutting performance, which results in fewer artifacts and less bleeding. These factors are supposed to accelerate the segment’s growth.
The disposable biopsy forceps, which have a length of 2300mm, are becoming more and more popular on the market and are anticipated to hold the greatest market share of 37.7% in 2023. Infants and young children typically require smaller forceps that can pass through a 2.2 mm biopsy canal.
Additionally, precision jaws, no tearing, and a small wound are all characteristics of the 2300 mm length forceps, which stimulate the segments’ growth. For instance, Jiangxi ZhuoRuiHua Medical Instruments Co., Ltd a manufacturer and producer of endoscopic diagnostic instruments and consumables came out with 2300mm disposable biopsy forceps for enteroscopy specially designed for adults & children. It is coated with super lubricious PE for better glide and protection.
The upper GI endoscopy segment is expected to account for the highest market share of 49.3% by 2023 and is supposed to gain a high share during the forecast period. The demand for upper GI endoscopic operations has increased due to the rising prevalence of gastroesophageal reflux disease (GERD) among the expanding population.
For instance, according to a study published by Annals of Medicine in 2022, around 783.95 million cases of gastroesophageal reflux disease (GERD) were found globally. Additionally, it also states that GERD will continue to be a major public health burden due to increasing years lived with diseases.
Additionally, upper GI endoscopy is a rapid, painless technique that is very safe for patients.
Hospitals are expected to hold the highest market share value of around 43.1% in 2023. In hospitals during endoscopy, disposable biopsy forceps are shown to be consistently and dependably effective for taking adequate-sized biopsy samples and preventing the spread of infection between patients.
Therefore, the disposable biopsy forceps eliminate cross-contamination which enhances patient and staff safety so this factor is supposed to boost the segment’s growth overall.
Key players are focusing on novel and innovative approaches for the development of cold disposable biopsy forceps driven by emerging cases of infectious diseases and the lack of advanced methods for efficient disease detection.
The strategy of sales footprint expansion, new product launches, and approvals, by key manufacturers, is further strengthening their market presence.
For instance,
Similarly, recent developments related to companies manufacturing cold disposable biopsy forceps have been tracked by the team at Future Market Insight, which is available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2016 to 2022 |
| Market Analysis | USD Million for Value, (Units) for Volume |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | The USA, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia and New Zealand, GCC Countries, Turkey, South Africa, and North Africa |
| Key Market Segments Covered | Product, Diameter, Length, Application, End User, and Region |
| Key Companies Profiled | Olympus Corporation; Boston Scientific Corporation; STERIS; CONMED Corporation; Cook Medical; Micro-Tech Endoscopy; Anrei Medical |
| Customization & Pricing | Available upon Request |
The market in 2023 is valued at USD 634.6 million.
Hospitals segment to hold a 43.1% market share in 2023.
The United States is likely to generate 49.5% in 2023.
The market was valued at USD 2 billion in 2022.
A whopping 66% of the value will be generated by 2033.
1. Executive Summary | Cold Disposable Biopsy Forceps Market 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 6. Global Market Volume (Units) Analysis 2016 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in US$ million) Analysis 2016 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, by Product 9.1. Oval Cup 9.2. Oval Cup with Needle 9.3. Alligator Jaw 9.4. Alligator Jaw with Needle 10. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, by Diameter 10.1. 1.2mm 10.2. 1.8mm 10.3. 2.0mm 10.4. 2.4mm 10.5. 2.8mm 10.6. 3.7mm 10.7. 4.0mm 11. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, by Length 11.1. 1150 mm 11.2. 1550 mm 11.3. 2300 mm 12. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, by Application 12.1. Enteroscopy 12.2. Upper GI Endoscopy 12.3. Lower GI Endoscopy 12.4. Bronchoscopy 12.5. Others 13. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, by End User 13.1. Hospitals 13.2. Ambulatory Surgical Centers 13.3. Specialty Clinics 13.4. Diagnostic Laboratories 13.5. Cancer Research Institutes 14. Global Market Analysis 2016 to 2022 and Forecast 2023 to 2033, by Region 14.1. North America 14.2. Latin America 14.3. Europe 14.4. East Asia 14.5. South Asia 14.6. Oceania 14.7. Middle East and Africa (MEA) 15. North America Market Analysis 2016 to 2022 and Forecast 2023 to 2033 16. Latin America Market Analysis 2016 to 2022 and Forecast 2023 to 2033 17. Europe Market Analysis 2016 to 2022 and Forecast 2023 to 2033 18. South Asia Market Analysis 2016 to 2022 and Forecast 2023 to 2033 19. East Asia Market Analysis 2016 to 2022 and Forecast 2023 to 2033 20. Oceania Market 2016 to 2022 and Forecast 2023 to 2033 21. Middle East and Africa (MEA) Market Analysis 2016 to 2022 and Forecast 2023 to 2033 22. Market Structure Analysis 23. Competition Analysis 23.1. Olympus Corporation 23.2. Boston Scientific Corporation 23.3. STERIS 23.4. CONMED Corporation 23.5. Cook Medical 23.6. Micro-Tech Endoscopy 23.7. Anrei Medical 24. Assumptions and Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports
Cold Disposable Biopsy Forceps Market
